Papers: 10.1371/journal.pone.0188407

https://doi.org/10.1371/journal.pone.0188407

Docking analysis and the possibility of prediction efficacy for an anti-IL-13 biopharmaceutical treatment with tralokinumab and lebrikizumab for bronchial asthma

Cited by: 15
Author(s): Yutaka Nakamura, Aki Sugano, Mika Ohta, Yutaka Takaoka
Published: almost 9 years ago

Software Mentions 1